Dental Implants
Conditions
Interventions
This is a randomized controlled clinical trial with three parallel arms, double-blind. A total of 51 participants meeting eligibility criteria will be randomly allocated to one of three intervention g
E06.761.726.794
Sponsors
Universidade Estadual de Maringá
Universidade Estadual de Maringá
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male and female participants; aged 18 or over; presence of at least one dental implant supporting single or multiple prostheses, with at least 1 year in function; diagnosis of peri-implant mucositis: presence of at least two sites with bleeding after probing; availability to participate for the 6 months of the study; have all upper and/or lower anterior incisors
Exclusion criteria
Exclusion criteria: Medical history that includes serious medical conditions or communicable diseases such as, but not limited to: human immunodeficiency virus (HIV), diabetes outside of glycemic target, rheumatic fever and bone diseases. Presence of untreated periodontitis and/or dental caries. Presence of peri-implantitis: presence of bleeding on probing and/or suppuration, probing depths greater than or equal to 6mm and level bone greater than or equal to 3mm. Motor or cognitive difficulties detected at the time of supervised hygiene. Use of antibiotics in the last month prior to the study. History of allergy to therapeutic ingredients (Chlorhexidine and Fluorides). Alcoholics and Smokers. Pregnant and breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that dentifrices with therapeutic agents Chlorhexidine and enzymes will provide an additional benefit in the resolution of inflammation of the peri-implant mucosa and its recurrence, through the reduction of bleeding on probing and the accumulation of biofilm after 6 months when compared to dentifrice. regular fluoridated | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to observe that the chlorhexidine dentifrice will promote acceptable staining of the surface of the teeth and implant prosthesis when compared to regular fluoridated dentifrice, after 6 months of use | — |
Countries
Brazil
Contacts
Public ContactDébora Souza
Universidade Estadual de Maringá
Outcome results
None listed